FUSN Projected Dividend Yield
Fusion Pharmaceuticals Inc ( NASDAQ : FUSN )Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines. Co. has developed its Targeted Alpha Therapies, or TAT, platform together with its proprietary Fast-Clear linker technology to enable them to connect alpha particle emitting isotopes to antibodies and other targeting molecules in order to selectively deliver the alpha particle payloads to tumors. Co. serves health care sectors in Canada. 20 YEAR PERFORMANCE RESULTS |
FUSN Dividend History Detail FUSN Dividend News FUSN Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |